To investigate the association of the epithelial to mesenchymal transition (EMT)–inducing transcription factor ZEB2 (zinc finger E box–binding homeobox 2), survival outcomes, and the efficacy of ZEB2 as a biomarker when added as refinement to TNM staging after curative intent surgery for CRC. The gene discussed is ZEB2; the disease is colorectal carcinoma.